Core Laboratories (CLB) Competitors

$14.24 +0.02 (+0.11%)

Closing price 05/22/2026 03:59 PM Eastern

Extended Trading

$14.04 -0.19 (-1.36%)

As of 05/22/2026 06:38 PM Eastern

CLB vs. PTEN, HAL, HP, MGY, and NBR

Should you buy Core Laboratories stock or one of its competitors? MarketBeat compares Core Laboratories with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Core Laboratories include Patterson-UTI Energy (PTEN), Halliburton (HAL), Helmerich & Payne (HP), Magnolia Oil & Gas (MGY), and Nabors Industries (NBR). These companies are all part of the "energy" sector.

How does Core Laboratories compare to Patterson-UTI Energy?

Core Laboratories (NYSE:CLB) and Patterson-UTI Energy (NASDAQ:PTEN) are both energy companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, institutional ownership, dividends, profitability and earnings.

97.8% of Core Laboratories shares are held by institutional investors. Comparatively, 97.9% of Patterson-UTI Energy shares are held by institutional investors. 1.3% of Core Laboratories shares are held by company insiders. Comparatively, 2.2% of Patterson-UTI Energy shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Core Laboratories presently has a consensus price target of $12.00, suggesting a potential downside of 15.70%. Patterson-UTI Energy has a consensus price target of $11.80, suggesting a potential downside of 4.14%. Given Patterson-UTI Energy's stronger consensus rating and higher probable upside, analysts clearly believe Patterson-UTI Energy is more favorable than Core Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Core Laboratories	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Patterson-UTI Energy	2 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.50

Core Laboratories has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market. Comparatively, Patterson-UTI Energy has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market.

Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.3%. Patterson-UTI Energy pays an annual dividend of $0.40 per share and has a dividend yield of 3.2%. Core Laboratories pays out 6.2% of its earnings in the form of a dividend. Patterson-UTI Energy pays out -129.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Patterson-UTI Energy is clearly the better dividend stock, given its higher yield and lower payout ratio.

Core Laboratories has higher earnings, but lower revenue than Patterson-UTI Energy. Patterson-UTI Energy is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Core Laboratories	$524.73M	1.25	$29.67M	$0.65	21.90
Patterson-UTI Energy	$4.83B	0.97	-$93.64M	-$0.31	N/A

In the previous week, Core Laboratories had 8 more articles in the media than Patterson-UTI Energy. MarketBeat recorded 12 mentions for Core Laboratories and 4 mentions for Patterson-UTI Energy. Core Laboratories' average media sentiment score of 1.10 beat Patterson-UTI Energy's score of 1.05 indicating that Core Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Core Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Patterson-UTI Energy	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Core Laboratories has a net margin of 5.94% compared to Patterson-UTI Energy's net margin of -2.56%. Core Laboratories' return on equity of 11.52% beat Patterson-UTI Energy's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Core Laboratories	5.94%	11.52%	5.32%
Patterson-UTI Energy	-2.56%	-2.32%	-1.37%

Summary

Core Laboratories beats Patterson-UTI Energy on 10 of the 19 factors compared between the two stocks.

How does Core Laboratories compare to Halliburton?

Core Laboratories (NYSE:CLB) and Halliburton (NYSE:HAL) are both energy companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, media sentiment and earnings.

Halliburton has higher revenue and earnings than Core Laboratories. Core Laboratories is trading at a lower price-to-earnings ratio than Halliburton, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Core Laboratories	$524.73M	1.25	$29.67M	$0.65	21.90
Halliburton	$22.18B	1.56	$1.28B	$1.82	22.80

Core Laboratories currently has a consensus target price of $12.00, suggesting a potential downside of 15.70%. Halliburton has a consensus target price of $42.86, suggesting a potential upside of 3.28%. Given Halliburton's stronger consensus rating and higher possible upside, analysts clearly believe Halliburton is more favorable than Core Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Core Laboratories	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Halliburton	1 Sell rating(s)	5 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.71

In the previous week, Halliburton had 10 more articles in the media than Core Laboratories. MarketBeat recorded 22 mentions for Halliburton and 12 mentions for Core Laboratories. Core Laboratories' average media sentiment score of 1.10 beat Halliburton's score of 0.74 indicating that Core Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Core Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Halliburton	9 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Core Laboratories has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market. Comparatively, Halliburton has a beta of 0.73, meaning that its stock price is 27% less volatile than the broader market.

Halliburton has a net margin of 6.95% compared to Core Laboratories' net margin of 5.94%. Halliburton's return on equity of 19.04% beat Core Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Core Laboratories	5.94%	11.52%	5.32%
Halliburton	6.95%	19.04%	7.96%

97.8% of Core Laboratories shares are owned by institutional investors. Comparatively, 85.2% of Halliburton shares are owned by institutional investors. 1.3% of Core Laboratories shares are owned by insiders. Comparatively, 0.6% of Halliburton shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.3%. Halliburton pays an annual dividend of $0.68 per share and has a dividend yield of 1.6%. Core Laboratories pays out 6.2% of its earnings in the form of a dividend. Halliburton pays out 37.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Halliburton has increased its dividend for 4 consecutive years. Halliburton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Halliburton beats Core Laboratories on 14 of the 19 factors compared between the two stocks.

How does Core Laboratories compare to Helmerich & Payne?

Core Laboratories (NYSE:CLB) and Helmerich & Payne (NYSE:HP) are both energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.

Core Laboratories has higher earnings, but lower revenue than Helmerich & Payne. Helmerich & Payne is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Core Laboratories	$524.73M	1.25	$29.67M	$0.65	21.90
Helmerich & Payne	$4.00B	1.00	-$163.70M	-$3.79	N/A

97.8% of Core Laboratories shares are owned by institutional investors. Comparatively, 96.1% of Helmerich & Payne shares are owned by institutional investors. 1.3% of Core Laboratories shares are owned by insiders. Comparatively, 4.4% of Helmerich & Payne shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Core Laboratories and Core Laboratories both had 12 articles in the media. Core Laboratories' average media sentiment score of 1.10 beat Helmerich & Payne's score of 0.55 indicating that Core Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Core Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Helmerich & Payne	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Core Laboratories has a beta of 0.99, suggesting that its share price is 1% less volatile than the broader market. Comparatively, Helmerich & Payne has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market.

Core Laboratories has a net margin of 5.94% compared to Helmerich & Payne's net margin of -9.38%. Core Laboratories' return on equity of 11.52% beat Helmerich & Payne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Core Laboratories	5.94%	11.52%	5.32%
Helmerich & Payne	-9.38%	-1.16%	-0.48%

Core Laboratories presently has a consensus price target of $12.00, suggesting a potential downside of 15.70%. Helmerich & Payne has a consensus price target of $39.70, suggesting a potential downside of 0.44%. Given Helmerich & Payne's stronger consensus rating and higher probable upside, analysts plainly believe Helmerich & Payne is more favorable than Core Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Core Laboratories	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Helmerich & Payne	2 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.3%. Helmerich & Payne pays an annual dividend of $1.00 per share and has a dividend yield of 2.5%. Core Laboratories pays out 6.2% of its earnings in the form of a dividend. Helmerich & Payne pays out -26.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Helmerich & Payne is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Core Laboratories beats Helmerich & Payne on 10 of the 17 factors compared between the two stocks.

How does Core Laboratories compare to Magnolia Oil & Gas?

Core Laboratories (NYSE:CLB) and Magnolia Oil & Gas (NYSE:MGY) are both energy companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk, media sentiment and dividends.

In the previous week, Magnolia Oil & Gas had 8 more articles in the media than Core Laboratories. MarketBeat recorded 20 mentions for Magnolia Oil & Gas and 12 mentions for Core Laboratories. Core Laboratories' average media sentiment score of 1.10 beat Magnolia Oil & Gas' score of 0.98 indicating that Core Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Core Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Magnolia Oil & Gas	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Core Laboratories currently has a consensus target price of $12.00, suggesting a potential downside of 15.70%. Magnolia Oil & Gas has a consensus target price of $31.00, suggesting a potential upside of 5.86%. Given Magnolia Oil & Gas' stronger consensus rating and higher possible upside, analysts clearly believe Magnolia Oil & Gas is more favorable than Core Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Core Laboratories	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Magnolia Oil & Gas	0 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.41

Magnolia Oil & Gas has a net margin of 24.40% compared to Core Laboratories' net margin of 5.94%. Magnolia Oil & Gas' return on equity of 16.28% beat Core Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Core Laboratories	5.94%	11.52%	5.32%
Magnolia Oil & Gas	24.40%	16.28%	11.26%

Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.3%. Magnolia Oil & Gas pays an annual dividend of $0.66 per share and has a dividend yield of 2.3%. Core Laboratories pays out 6.2% of its earnings in the form of a dividend. Magnolia Oil & Gas pays out 38.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Magnolia Oil & Gas has raised its dividend for 3 consecutive years. Magnolia Oil & Gas is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Core Laboratories has a beta of 0.99, suggesting that its share price is 1% less volatile than the broader market. Comparatively, Magnolia Oil & Gas has a beta of 0.75, suggesting that its share price is 25% less volatile than the broader market.

Magnolia Oil & Gas has higher revenue and earnings than Core Laboratories. Magnolia Oil & Gas is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Core Laboratories	$524.73M	1.25	$29.67M	$0.65	21.90
Magnolia Oil & Gas	$1.31B	4.13	$325.25M	$1.72	17.03

97.8% of Core Laboratories shares are held by institutional investors. Comparatively, 94.7% of Magnolia Oil & Gas shares are held by institutional investors. 1.3% of Core Laboratories shares are held by insiders. Comparatively, 0.9% of Magnolia Oil & Gas shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Magnolia Oil & Gas beats Core Laboratories on 13 of the 19 factors compared between the two stocks.

How does Core Laboratories compare to Nabors Industries?

Nabors Industries (NYSE:NBR) and Core Laboratories (NYSE:CLB) are both small-cap energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

81.9% of Nabors Industries shares are held by institutional investors. Comparatively, 97.8% of Core Laboratories shares are held by institutional investors. 5.4% of Nabors Industries shares are held by insiders. Comparatively, 1.3% of Core Laboratories shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Nabors Industries has higher revenue and earnings than Core Laboratories. Nabors Industries is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nabors Industries	$3.21B	0.48	$286.62M	$12.77	8.22
Core Laboratories	$524.73M	1.25	$29.67M	$0.65	21.90

In the previous week, Core Laboratories had 10 more articles in the media than Nabors Industries. MarketBeat recorded 12 mentions for Core Laboratories and 2 mentions for Nabors Industries. Core Laboratories' average media sentiment score of 1.10 beat Nabors Industries' score of 0.61 indicating that Core Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nabors Industries	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Core Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Nabors Industries has a net margin of 7.32% compared to Core Laboratories' net margin of 5.94%. Core Laboratories' return on equity of 11.52% beat Nabors Industries' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nabors Industries	7.32%	-8.66%	-1.59%
Core Laboratories	5.94%	11.52%	5.32%

Nabors Industries currently has a consensus target price of $93.63, suggesting a potential downside of 10.80%. Core Laboratories has a consensus target price of $12.00, suggesting a potential downside of 15.70%. Given Nabors Industries' stronger consensus rating and higher possible upside, research analysts plainly believe Nabors Industries is more favorable than Core Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nabors Industries	1 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.13
Core Laboratories	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Nabors Industries has a beta of 1.01, suggesting that its stock price is 1% more volatile than the broader market. Comparatively, Core Laboratories has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market.

Summary

Nabors Industries beats Core Laboratories on 9 of the 16 factors compared between the two stocks.

Get Core Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CLB vs. The Competition

Export

Metric	Core Laboratories	OIL Industry	Energy Sector	NYSE Exchange
Market Cap	$656.19M	$9.86B	$10.57B	$23.18B
Dividend Yield	0.28%	2.37%	10.23%	4.10%
P/E Ratio	21.90	24.62	21.11	30.65
Price / Sales	1.25	1.76	1,003.92	14.66
Price / Cash	13.31	11.91	38.74	25.12
Price / Book	2.38	2.86	4.66	4.74
Net Income	$29.67M	$373.98M	$4.24B	$1.07B
7 Day Performance	4.72%	-2.86%	-0.26%	1.45%
1 Month Performance	-18.47%	-0.66%	2.28%	1.58%
1 Year Performance	30.90%	83.13%	54.41%	28.44%

Core Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CLB Core Laboratories	1.8054 of 5 stars	$14.24 +0.1%	$12.00 -15.7%	+30.9%	$656.19M	$524.73M	21.90	3,300	Analyst Downgrade
PTEN Patterson-UTI Energy	2.7977 of 5 stars	$12.85 0.0%	$11.80 -8.1%	+115.2%	$4.87B	$4.83B	N/A	7,900	Positive News
HAL Halliburton	3.9769 of 5 stars	$43.10 +0.7%	$42.45 -1.5%	+108.4%	$36.01B	$22.18B	23.69	46,000	Dividend Announcement
HP Helmerich & Payne	2.4362 of 5 stars	$41.41 -0.3%	$39.70 -4.1%	+157.4%	$4.14B	$4.00B	N/A	6,200	Analyst Revision
MGY Magnolia Oil & Gas	3.4828 of 5 stars	$30.08 +0.6%	$31.00 +3.1%	+35.1%	$5.56B	$1.31B	17.47	210	Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CLB) was last updated on 5/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Core Laboratories (CLB) Competitors

CLB vs. PTEN, HAL, HP, MGY, and NBR

How does Core Laboratories compare to Patterson-UTI Energy?

Summary

How does Core Laboratories compare to Halliburton?

Summary

How does Core Laboratories compare to Helmerich & Payne?

Summary

How does Core Laboratories compare to Magnolia Oil & Gas?

Summary

How does Core Laboratories compare to Nabors Industries?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLB vs. The Competition

Core Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Core Laboratories (CLB) Competitors

CLB vs. PTEN, HAL, HP, MGY, and NBR

How does Core Laboratories compare to Patterson-UTI Energy?

Do institutionals & insiders have more ownership in CLB or PTEN?

Do analysts prefer CLB or PTEN?

Which has more risk & volatility, CLB or PTEN?

Is CLB or PTEN a better dividend stock?

Which has stronger valuation & earnings, CLB or PTEN?

Does the media refer more to CLB or PTEN?

Is CLB or PTEN more profitable?

Summary

How does Core Laboratories compare to Halliburton?

Which has preferable earnings & valuation, CLB or HAL?

Do analysts prefer CLB or HAL?

Does the media prefer CLB or HAL?

Which has more volatility & risk, CLB or HAL?

Is CLB or HAL more profitable?

Do insiders & institutionals believe in CLB or HAL?

Is CLB or HAL a better dividend stock?

Summary

How does Core Laboratories compare to Helmerich & Payne?

Which has preferable earnings & valuation, CLB or HP?

Do institutionals & insiders hold more shares of CLB or HP?

Does the media favor CLB or HP?

Which has more risk and volatility, CLB or HP?

Is CLB or HP more profitable?

Do analysts recommend CLB or HP?

Is CLB or HP a better dividend stock?

Summary

How does Core Laboratories compare to Magnolia Oil & Gas?

Does the media refer more to CLB or MGY?

Do analysts recommend CLB or MGY?

Is CLB or MGY more profitable?

Is CLB or MGY a better dividend stock?

Which has more risk and volatility, CLB or MGY?

Which has higher valuation and earnings, CLB or MGY?

Do insiders & institutionals have more ownership in CLB or MGY?

Summary

How does Core Laboratories compare to Nabors Industries?

Do insiders & institutionals have more ownership in NBR or CLB?

Which has stronger valuation & earnings, NBR or CLB?

Does the media prefer NBR or CLB?

Is NBR or CLB more profitable?

Do analysts recommend NBR or CLB?

Which has more risk & volatility, NBR or CLB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLB vs. The Competition

Core Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools